@article{b69404611b124f8e8c29d68b75f85383,
title = "ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia",
author = "Swagata Goswami and Chiang, {Chi Ling} and Kevan Zapolnik and Jessica Nunes and Ann Ventura and Xiaokui Mo and Zhiliang Xie and Lee, {L. James} and Sivasubramanian Baskar and Christoph Rader and Byrd, {John C.} and Mitch Phelps and Bhavana Bhatnagar and Natarajan Muthusamy",
note = "Funding Information: The authors are grateful to the ALL patients who contributed to these studies, the Ohio State University (OSU) Comprehensive Cancer Center Leukemia Tissue Bank Shared Resource (P30CA016058), USA. This work was supported by National Institute of Health (NIH, USA) R01-CA197844-01, R35 CA197734, P50-CA140158, OSU Division of Hematology DSRP (NM and BB), Robert J. Anthony Leukemia Fund (USA). SG is funded by National Cancer Institute (NCI, USA) 1F99CA245813-01 and previously by OSU Pelotonia Graduate Fellowship. SG planned, designed and performed the experiments, analyzed data, wrote the drafts of the paper. CL, KZ, XZ assisted with the experiments. X.M. performed the statistical analysis. JL, SB, CR, JCB and MP provided necessary reagents, supported components of the research. JCB and BB contributed to the patient care and/or provided translation insight to the study. NM conceived the idea, designed experiments, supervised the study, sought funding, reviewed drafts and approved the final version for submission. All authors reviewed the data and the manuscript, and agreed with submission for publication. NM and JCB are co-inventors of OSU-2S for which The Ohio State University owns the patent. CR and SB are co-inventors of mAb 2A2 for which the NIH owns the patent. Funding Information: The authors are grateful to the ALL patients who contributed to these studies, the Ohio State University (OSU) Comprehensive Cancer Center Leukemia Tissue Bank Shared Resource ( P30CA016058 ), USA. This work was supported by National Institute of Health (NIH, USA) R01-CA197844-01 , R35 CA197734 , P50-CA140158 , OSU Division of Hematology DSRP (NM and BB), Robert J. Anthony Leukemia Fund (USA). SG is funded by National Cancer Institute (NCI, USA) 1F99CA245813-01 and previously by OSU Pelotonia Graduate Fellowship. ",
year = "2022",
month = jul,
doi = "10.1016/j.leukres.2022.106872",
language = "English",
volume = "118",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Ltd",
}
